within Pharmacolibrary.Drugs.ATC.J;

model J01CA15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 85 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Talampicillin is a prodrug of ampicillin and is classified as an aminopenicillin antibiotic. It was developed to improve the oral bioavailability of ampicillin. Talampicillin was formerly used for the treatment of bacterial infections, including respiratory, urinary tract, and gastrointestinal infections, but it is no longer widely used or approved in most countries today due to the availability of better alternatives and concerns over efficacy.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals, as no direct published PK studies for talampicillin were identified. Derived based on the known PK properties of aminopenicillins and prodrugs such as talampicillin.</p><h4>References</h4><ol><li><p>Tachibana, A, et al., &amp; Yano, K (1978). [Talampicillin hydrochloride: Comparison with amoxicillin and ampicillin in the antibacterial activity and pharmacokinetics (author&#x27;s transl)]. <i>The Japanese journal of antibiotics</i> 31(3) 166–176. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/246947/&quot;>https://pubmed.ncbi.nlm.nih.gov/246947</a></p></li><li><p>Ensink, JM, et al., &amp; Fluitman, MA (1996). Oral bioavailability and in vitro stability of pivampicillin, bacampicillin, talampicillin, and ampicillin in horses. <i>American journal of veterinary research</i> 57(7) 1021–1024. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8807014/&quot;>https://pubmed.ncbi.nlm.nih.gov/8807014</a></p></li><li><p>Clayton, JP, et al., &amp; Ferres, H (1974). BRL.8988 (talampicillin), a well-absorbed oral form of ampicillin. <i>Antimicrobial agents and chemotherapy</i> 5(6) 670–671. DOI:<a href=&quot;https://doi.org/10.1128/AAC.5.6.670&quot;>10.1128/AAC.5.6.670</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15825424/&quot;>https://pubmed.ncbi.nlm.nih.gov/15825424</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01CA15;
